- Home
- OPAD vs RVPH Comparison
OPAD vs RVPH Comparison
Compare OPAD & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- RVPH
- Stock Information
- Founded
- OPAD 2015
- RVPH 2006
- Country
- OPAD United States
- RVPH United States
- Employees
- OPAD N/A
- RVPH N/A
- Industry
- OPAD Real Estate
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- OPAD Finance
- RVPH Health Care
- Exchange
- OPAD Nasdaq
- RVPH Nasdaq
- Market Cap
- OPAD 25.3M
- RVPH 32.8M
- IPO Year
- OPAD N/A
- RVPH N/A
- Fundamental
- Price
- OPAD $1.52
- RVPH $0.39
- Analyst Decision
- OPAD Hold
- RVPH Strong Buy
- Analyst Count
- OPAD 5
- RVPH 5
- Target Price
- OPAD $2.38
- RVPH $9.00
- AVG Volume (30 Days)
- OPAD 148.4K
- RVPH 3.7M
- Earning Date
- OPAD 08-04-2025
- RVPH 08-13-2025
- Dividend Yield
- OPAD N/A
- RVPH N/A
- EPS Growth
- OPAD N/A
- RVPH N/A
- EPS
- OPAD N/A
- RVPH N/A
- Revenue
- OPAD $794,159,000.00
- RVPH N/A
- Revenue This Year
- OPAD N/A
- RVPH N/A
- Revenue Next Year
- OPAD $40.79
- RVPH N/A
- P/E Ratio
- OPAD N/A
- RVPH N/A
- Revenue Growth
- OPAD N/A
- RVPH N/A
- 52 Week Low
- OPAD $0.91
- RVPH $0.30
- 52 Week High
- OPAD $5.13
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- OPAD 64.86
- RVPH 35.22
- Support Level
- OPAD $1.31
- RVPH $0.38
- Resistance Level
- OPAD $1.52
- RVPH $0.45
- Average True Range (ATR)
- OPAD 0.14
- RVPH 0.05
- MACD
- OPAD 0.04
- RVPH 0.01
- Stochastic Oscillator
- OPAD 69.32
- RVPH 17.57
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.